Smooth muscle caveolae differentially regulate specific agonist induced bladder contractions

Neurourology and Urodynamics

Volumn 26, Issue 1, 2007, Pages 71-80

  Cristofaro, V ^a,b   Peters, C A ^c   Yalla, S V ^a,b   Sullivan, Maryrose P ^a,b,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

Bladder; Caveolae; Smooth muscle

Indexed keywords

ANGIOTENSIN II; BRADYKININ; CARBACHOL; CAVEOLIN; CHOLESTEROL; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; METHYL BETA CYCLODEXTRIN; PHENYLEPHRINE; POTASSIUM CHLORIDE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BLADDER CONTRACTION; BLADDER MUSCLE; CAVEOLA; CONFERENCE PAPER; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; ULTRASTRUCTURE ANALYSIS AND ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; BETA-CYCLODEXTRINS; BRADYKININ; CARBACHOL; CAVEOLAE; CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; CHOLINERGIC AGONISTS; MALE; MICROSCOPY, ELECTRON; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MYOCYTES, SMOOTH MUSCLE; PHENYLEPHRINE; POTASSIUM CHLORIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; SEROTONIN; SIGNAL TRANSDUCTION; URINARY BLADDER; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 33846631269     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20361     Document Type: Conference Paper

References (45)

1. Bakircioglu ME, Sievert KD, Lau A, et al. 2000. The effect of pregnancy and delivery on the function and ultrastructure of the rat bladder and urethra. BJU Int 85:350-61.
2. Bergdahl A, Sward K. 2004. Caveolae-associated signaling in smooth muscle. Can J Physiol Pharmacol 82:289-99.
3. Bhatnagar A, Sheffler DJ, Kroeze WK, et al. 2004. Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected gαq-coupled protein receptors. J Biol Chem 279:34614-23.
4. Burger K, Gimpl G, Fahrenholz F. 2000. Regulation of receptor function by cholesterol. Cell Mol Life Sci 57:1577-92.
5. Cai C, Zhu H, Chen J. 2004. Overexpression of caveolin-1 increases plasma membrane fluidity and reduces P-glycoprotein function in Hs578T/Doxq. Biochem Biophys Res Comm 320:868-74.
6. Cao G, Yang G, Timme TL, et al. 2003. Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis. Am J Pathol 162:1241-8.
7. Cohen AW, Hnasko R, Schubert W, et al. 2004. Role of Caveolae and Caveolins in Health and Disease. Physiol Rev 84:1341-79.
8. Daniel EE, Cowan W, Daniel VP. 1983. Structural basis for neural and myogenic control of human detrusor muscle. Can J Physiol Pharmacol 61:1247-73.
9. Darblade B, Caillaud D, Poirot M, et al. 2001. Alterations of plasmalemmal caveolae mimics endothelial dysfunction observed in atheromatus rabbit aorta. Cardiovasc Res 50:566-76.
10. 1 MF-2 smooth muscle cells. J Biol Chem 272:17858-66.
11. Dreja K, Voldstedlund M, Vinten J, et al. 2002. Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction. Arterioscer Thromb Vasc Biol 22:1267-72.
12. Elbadawi A, Atta MA. 1984. Intrinsic Neuromuscular defects in the neurogenic bladder. III. Transjunctional, short- and long-term ultrastructural changes in muscle cells of the decentralized feline bladder base following unilateral sacral ventral rhizotomy. Neurourol Urodyn 3:245-70.
13. Elbadawi A, Atta MA, Hanno AG-E. 1988. Intrinsic neuromuscular defects in the neurogenic bladder. VIII. Effects of unilateral pelvic and pelvic plexus neurectomy on ultrastructure of the feline bladder base. Neurourol Urodyn 7:77-92.
14. Elbadawi A, Yalla SV, Resnick NM. 1993. Structural basis of geriatric voiding dysfunction. II. Aging detrusor: Normal versus impaired contractility. J Urol 150:1657-67.
15. Elbadawi A, Yalla SV, Resnick NM. 1993a. Structural basis of geriatric voiding dysfunction. IV Bladder outlet obstruction. J Urol 150:1681-95.
16. Fiorica-Howells E, Hen R, Gingrich J, et al. 2002. 5-HT(2A) receptors: Location and functional analysis in intestine of wild-type and 5-HT(2A) knockout mice. Am J Physiol Gastrointst Liver Physiol 282:G877-93.
17. Frank PG, Woodman SE, Park DS, et al. 2003. Caveolin, caveolae, and endothelial cell function. Arterioscler Tromb Vasc Biol 23:1161-8.
18. Fujita T, Toya Y, Iwatsubo K, et al. 2001. Accumulation of molecules involved in a1-adrenergic signal within caveolae: Caveolin expression and the development of cardiac hypertrophy. Cardiovasc Res 51:709-16.
19. Galbiati F, Razani B, Lisanti MP. 2001. Emerging themes in lipid rafts and caveolae. Cell 106:403-11.
20. Hnasko R, Lisanti MP. 2003. The biology of caveolae: Lessons from caveolin knockout mice and implications for human disease. Mol Interventions 3:445-63.
21. Ishikawa H. 1968. Formation of elaborate networks of T-system tubules in cultured skeletal muscle with special reference to the T-system formation. J Cell Biol 38:51-66.
22. Ishizaka N, Griendling KK, Lassegue B, et al. 1998. Angiotensin II type I receptor: Relationship with caveolae and caveolin after initial agonist stimulation. Hypertension 32:459-66.
23. Jc HD, Gallant C, Leavis PC, et al. 2003. Caveolin-1 regulates contractility in differentiated vascular smooth muscle. Am J Physiol Heart Circ Physiol 286:H91-8.
24. Ju H, Venema VJ, Liang H, et al. 2000. Bradykinin activates the Janus-activated kinase/signal transducers and activators of transcription pathway in vascular endothelial cells: Localization of JAK/STAT signaling protein in plasmalemmal caveolae. Biochem J 351:257-64.
25. Kim HJ, Lee G, Kim DH, et al. 2002. Acute effects of serotonin on rat bladder contractility. Urol Int; 68:44-8.
26. Kogo H, Ito SY, Moritoki Y, et al. 2006. Differential expression of caveolin-3 in mouse smooth muscle cell in vivo. Cell Tissue Res 324:291-300.
27. Lai HH, Boone TB, Yang G, et al. 2004. Loss of caveolin-1 expression is associated with disruption of muscarinic cholinergic activities in the urinary bladder. Neurochem Int 45:1185-93.
28. Murakumo M, Ushiki T, Koyanagi T, Abe K. 1993. Scanning electron microscopic studies of smooth muscle cells and their collagen fibrillar sheaths in empty, distended and contracted urinary bladders of the guinea pig. Arch Histol Cytol 56:441-9.
29. Ostrom RS, Insel PA. 2004. The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: Implications for molecular pharmacology. Br J Pharm 143:235-45.
30. Palade GE. 1953. Fine structure of blood capillaries. J Appl Phys 24:1424.
31. Razani B, Woodman SE, Lisanti MP. 2002. Caveolae: From cell biology to animal physiology. Pharmacol Rev 54:431-67.
32. + current by optical isomers of cholesterol. Biophys J 83:3211-22.
33. Sargiacomo M, Sudol M, Tang Z, et al. 1993. Signal transducing molecules and glycolsil-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 122:789-807.
34. Schroeder F, Gallegos AM, Atshaves BP, et al. 2001. Recent advances in membrane microdomains: Rafts, caveolae, and intracellular cholesterol trafficking. Exp Biol Med 226:873-90.
35. Segal SS, Brett SE, Sessa WC. 1999. Codistribution of NOS and caveolin throughout peripheral vasculature and skeletal muscle of hamster. Am J Physiol 277:h1167-77.
36. Shaul PW, Anderson RG. 1998. Role of plasmalemmal caveolae in signal transduction. Am J Physiol 64:749-74.
37. Song KS, Sherer PE, Tang Z, et al. 1996. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and cofractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 271:15160-5.
38. Stehr M, Adam RM, Khoury J, et al. 2003. Platelet derived growth Factor-Bb is a potent mitogen for rat ureteral and human bladder smooth muscle cells: Dependence on lipid rafts for cell signaling. J Urol 169:1165-70.
39. Stehr M, Estrada CR, Khoury J, et al. 2004. Caveolae are negative regulators of transforming growth factor-β1 signaling in ureteral smooth muscle cells. J Urol 172:2451-5.
40. Taggart MJ, Leavis P, Feron O, et al. 2000. Inhibition of PKCa and rhoA translocation in differentiated smooth muscle by a caveolin scaffolding domain peptide. Exp Cell Res 258:72-81.
41. Tang Z, Sherer PE, Okamoto T, et al. 1996. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 271:2255-61.
42. Thyberg J. 2002. Caveolae and cholesterol distribution in vascular smooth muscle cells of different phenotypes. J Histochem Cytochem 50:185-95.
43. Williams TM, Lisanti MP. 2004. The caveolin genes: From cell biology to medicine. Ann Med 36:584-95.
44. Woodman SE, Cheung MW, Tarr M, et al. 2004. Urogenital alterations in aged male caveolin-1 knockout mice. J Urol 171:950-7.
45. Yoshida A, Yamashita YS, Kaibara M, et al. 2002. 5-Hydroxytryptamine Receptors, Especially the 5-HT4 Receptor, in Guinea Pig Urinary Bladder. Jpn J Phramacol 89:349-55.